We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TELL
2826
DELISTED
Tellurian Inc.
TELL
$6K ﹤0.01%
+900
New +$6.96K
ETRN
2827
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$6K ﹤0.01%
+293
New +$6.18K
SCX
2828
DELISTED
The L.S. Starrett Company
SCX
$6K ﹤0.01%
+1,121
New +$6.21K
CAMP
2829
DELISTED
CalAmp Corp.
CAMP
$6K ﹤0.01%
20
+16
+400% +$6.64K
CCLP
2830
DELISTED
CSI Compressco LP
CCLP
$6K ﹤0.01%
+2,404
New +$10.7K
NSTG
2831
DELISTED
NanoString Technologies, Inc.
NSTG
$6K ﹤0.01%
+388
New +$6.15K
CHS
2832
DELISTED
Chicos FAS, Inc.
CHS
$6K ﹤0.01%
1,116
+804
+258% +$5.6K
RETA
2833
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$6K ﹤0.01%
102
-1,296
-93% -$79.1K
INFI
2834
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$6K ﹤0.01%
+5,448
New +$9.8K
ATTO
2835
DELISTED
Atento S.A.
ATTO
$6K ﹤0.01%
262
-39
-13% -$1.12K
MAXR
2836
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$6K ﹤0.01%
519
-12,781
-96% -$260K
BBBY
2837
DELISTED
Bed Bath & Beyond Inc
BBBY
$6K ﹤0.01%
513
-7,317
-93% -$95.6K
PRVB
2838
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$6K ﹤0.01%
3,217
-1,955
-38% -$5.62K
IDLB
2839
DELISTED
Invesco FTSE International Low Beta Equal Weight ETF
IDLB
$6K ﹤0.01%
+245
New +$6.66K
AHPI
2840
DELISTED
Allied Healthcare Products
AHPI
$6K ﹤0.01%
3,394
-814
-19% -$1.65K
NH
2841
DELISTED
NantHealth, Inc
NH
$6K ﹤0.01%
+693
New +$12.1K
RNDB
2842
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
$6K ﹤0.01%
+455
New +$6.91K
ALNA
2843
DELISTED
Allena Pharmaceuticals
ALNA
$6K ﹤0.01%
1,049
-723
-41% -$6.23K
NPTN
2844
DELISTED
NEOPHOTONICS CORP
NPTN
$6K ﹤0.01%
936
+336
+56% +$2.57K
ETTX
2845
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$6K ﹤0.01%
+1,398
New +$9.21K
GSS
2846
DELISTED
Golden Star Resources Ltd.
GSS
$6K ﹤0.01%
1,821
+58
+3% +$184
ADMS
2847
DELISTED
Adamas Pharmaceuticals
ADMS
$6K ﹤0.01%
756
-7,343
-91% -$95.5K
EBSB
2848
DELISTED
Meridian Bancorp, Inc.
EBSB
$6K ﹤0.01%
+421
New +$6.63K
QADB
2849
DELISTED
QAD Inc. Class B
QADB
$6K ﹤0.01%
215
+154
+252% +$5.07K
SYNC
2850
DELISTED
Synacor, Inc.
SYNC
$6K ﹤0.01%
4,143
+2,995
+261% +$5.28K

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.